JPRN-jRCT2080222013未知3 期
Randomized, phase III, comparative study of every-3-weeks dosing, weekly dosing of ABI-007, and weekly dosing of the conventional paclitaxel for patients with unresectable/recurrent gastric cancer refractory to prior chemotherapy containing fluoropyrimidines.
试验速览
- 阶段
- 3 期
- 入组人数
- 730
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Signed, written informed consent.
- •- Histologically or cytologically confirmed gastric adenocarcinoma.
- •- Eastern Cooperative Oncology Group (ECOG) performance status of 0, 1 or 2.
排除标准
- •- Past history of severe drug hypersensitivity
- •- Patient has pre-existing peripheral neuropathy of Grade 2, 3, or 4 (per CTCAE).
- •- Principal Investigators'(sub investigators') judgment on ineligibility
研究者
相似试验
已完成
3 期
A phase III, prospective randomised comparison of imatinib (STI571, Glivec/Gleevec) 400 mg daily versus imatinib 800 mg daily versus imatinib plus PEG interferon-alpha 2a (Pegasys) in patients with newly-diagnosed chronic phasechronic myeloid leukaemiaChronic Myeloid LeukaemiaCancerISRCTN59346371ewcastle upon Tyne Hospitals Trust (UK)2,466
尚未招募
3 期
To Study effectiveness of oral chemotherapy with low dose immunotherapy compared with chemotherapy in Head and Neck Cancer PatientsCTRI/2024/01/061661Tata Memorial Centre
已完成
3 期
Prospective, randomized phase III study of two intensified treatment groups [Methotrexate/Vinblastine/Adriamycin/Cisplatin (MVAC) vs. Gemcitabine/Cisplatin] in patients with inoperable or recurrent urothelial cancerurothelial cancerCancer - BladderACTRN12610000845033Hellenic Cooperative Oncology Group206
进行中（未招募）
不适用
A Randomized, Multicenter Phase 3 Study to Compare the Efficacy of Panitumumab in Combination with Chemotherapy to the Efficacy of Chemotherapy Alone in Patients with Previously Treated Metastatic Colorectal CancerPatients with Previously Treated Metastatic Colorectal CancerEUCTR2005-004676-20-PTAmgen Inc.1,100
进行中（未招募）
不适用
A Randomized, Multicenter Phase 3 Study to Compare the Efficacy of Panitumumab in Combination with Chemotherapy to the Efficacy of Chemotherapy Alone in Patients with Previously Treated Metastatic Colorectal CancerPatients with Previously Treated Metastatic Colorectal CancerEUCTR2005-004676-20-LTAmgen Limited1,100